Mimrylo, from Takeda and Protagonist, is a new kind of treatment for the blood cancer polycythemia vera.
BriefSTAT News
STAT+: FDA approves Protagonist and Takeda’s drug for rare blood cancer
BriefSTAT News
Mimrylo, from Takeda and Protagonist, is a new kind of treatment for the blood cancer polycythemia vera.